44.98
1.33%
0.59
Dopo l'orario di chiusura:
44.98
Precedente Chiudi:
$44.39
Aprire:
$43.99
Volume 24 ore:
2.41M
Relative Volume:
4.18
Capitalizzazione di mercato:
$2.08B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-58.42
EPS:
-0.77
Flusso di cassa netto:
$151.63M
1 W Prestazione:
-2.24%
1M Prestazione:
+7.56%
6M Prestazione:
+59.16%
1 anno Prestazione:
+18.59%
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.98 | 2.08B | 1.08B | -20.76M | 151.63M | -0.46 |
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-01-03 | Iniziato | Barclays | Underweight |
2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-09-26 | Reiterato | Wells Fargo | Underweight |
2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-09-09 | Iniziato | BofA Securities | Buy |
2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
2021-12-06 | Ripresa | Wells Fargo | Overweight |
2021-06-09 | Iniziato | JP Morgan | Neutral |
2021-05-24 | Iniziato | BTIG Research | Buy |
2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2020-12-08 | Iniziato | Berenberg | Buy |
2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-02-07 | Reiterato | Dougherty & Company | Buy |
2019-11-21 | Reiterato | Dougherty & Company | Buy |
2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
2019-03-07 | Reiterato | Dougherty & Company | Buy |
2018-06-29 | Ripresa | The Benchmark Company | Buy |
2017-09-05 | Reiterato | The Benchmark Company | Buy |
2017-07-28 | Reiterato | Dougherty & Company | Buy |
2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
2017-01-19 | Iniziato | Dougherty & Company | Buy |
2016-12-06 | Reiterato | The Benchmark Company | Buy |
2016-07-07 | Reiterato | FBR Capital | Outperform |
2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
2016-01-07 | Iniziato | The Benchmark Company | Buy |
2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
2015-10-30 | Reiterato | FBR Capital | Outperform |
2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
4 Healthcare Technology Innovators to Invest in Before the New Year - Zacks Investment Research
Why Omnicell (OMCL) Might be Well Poised for a Surge - MSN
Medication Management Market (2024-2032): Industry Insights, - openPR
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - Investing.com India
Don't Ignore The Insider Selling In Omnicell - Simply Wall St
Wellington Management Group LLP Sells 1,148,356 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell director Mark Parrish sells shares worth $567,638 By Investing.com - Investing.com Australia
Omnicell, Inc. (NASDAQ:OMCL) Short Interest Update - MarketBeat
Omnicell partners with Gollmann to expand pharmacy automation solutions - Pharmacy Business
Omnicell director Mark Parrish sells shares worth $567,638 - Investing.com India
Centiva Capital LP Sells 19,341 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 643,292 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Director Mark Parrish Sells 12,000 Shares of Omnicell Inc (OMCL) - GuruFocus.com
What Makes Omnicell (OMCL) a New Strong Buy Stock - MSN
Omnicell Introduces OmniSphere Platform, Stock to Gain - MSN
Future-Proofing Growth of Medication Management - openPR
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS - The Eastern Progress Online
Central Fill Pharmacy Automation Market Emerging Trends and Growth Prospects 2032 |Omnicell, McKesson, Swisslog - openPR
Pharmacy Dispensing Automation Market Likely to Boost Future Growth by 2031: McKesson, Omnicell, Cerner - openPR
Omnicell (NASDAQ:OMCL) Lowered to "Hold" Rating by StockNews.com - MarketBeat
Omnicell Announces OmniSphere - Business Wire
Central Fill Pharmacy Automation Market Projected To Witness Substantial Growth, 2024-2031: ARxIUM Inc., - EIN News
Pier Capital LLC Buys New Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Healthcare Robotics Market to See Huge Growth by 2030: Stryker Corporation, Omnicell, ARxIUM - openPR
SageView Advisory Group LLC Acquires Shares of 11,019 Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
How To Trade (OMCL) - Stock Traders Daily
Charles Schwab Investment Management Inc. Grows Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health - Barchart
Omnicell Inc (OMCL) Trading Down 3.62% on Dec 3 - GuruFocus.com
Martingale Asset Management L P Invests $507,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bridgewater Associates LP - MarketBeat
Rockefeller Capital Management L.P. Acquires 16,116 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Bellevue Group AG Reduces Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report? - MSN
Omnicell (NASDAQ:OMCL) Stock Price Down 3.7%Time to Sell? - MarketBeat
Dynamic Technology Lab Private Ltd Sells 15,351 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
OMCL (Omnicell) PE Ratio without NRI : 32.58 (As of Nov. 30, 2024) - GuruFocus.com
Algert Global LLC Trims Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Intech Investment Management LLC Makes New Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Should You Investigate Omnicell, Inc. (NASDAQ:OMCL) At US$48.46? - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues - Simply Wall St
Millrace Asset Group Inc. Invests $1.22 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Advantage Alpha Capital Partners LP Sells 24,485 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Central Fill Pharmacy Automation Market Future Business - openPR
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts - Investing.com
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts By Investing.com - Investing.com Canada
Global Surgery Management Software Market Size, Share - openPR
Pharmacy Automation System Market to Hit $11.21 Billion by 2030 | Becton, Dickinson and Company, Omnicell, - EIN News
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):